Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rasco, D.W.
106  Ergebnisse:
Personensuche X
?
1

Updated Findings and Biomarker Analysis From the Ongoing Ph..:

Papadopoulos, K.P. ; Gutierrez, M. ; Duska, L.R....
European Journal of Cancer.  174 (2022)  - p. S67 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Safety and efficacy of quavonlimab, a novel anti-CTLA-4 ant..:

Perets, R. ; Bar, J. ; Rasco, D.W....
Annals of Oncology.  32 (2021)  3 - p. 395-403 , 2021
Link: https://doi.org/10.1016/..
 
?
3

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in p..:

Papadopoulos, K P ; El-Rayes, B F ; Tolcher, A W...
British Journal of Cancer.  117 (2017)  11 - p. 1592-1599 , 2017
Link: https://doi.org/10.1038/..
 
?
4

First-in-human phase I study of copanlisib (BAY 80-6946), a..:

Patnaik, A. ; Appleman, L.J. ; Tolcher, A.W....
Annals of Oncology.  27 (2016)  10 - p. 1928-1940 , 2016
Link: https://doi.org/10.1093/..
 
?
5

300 Phase I study of two dosing schedules of the investigat..:

Rasco, D.W. ; Middleton, M.R. ; Gonzalez, R....
European Journal of Cancer.  51 (2015)  - p. S53-S54 , 2015
Link: https://doi.org/10.1016/..
 
?
6

18 Establishment and characterization of a Merkel Cell carc..:

Wick, M.J. ; Meade, J. ; Nehls, M....
European Journal of Cancer.  50 (2014)  - p. 12 , 2014
Link: https://doi.org/10.1016/..
 
?
7

364 First-in-human phase 1 study of MLN2480, an investigati..:

Middleton, M. ; Rasco, D.W. ; Olszanski, A.J....
European Journal of Cancer.  50 (2014)  - p. 117 , 2014
Link: https://doi.org/10.1016/..
 
?
8

551 Phase 1B study of CC-486 (oral azacitidine) in tumors a..:

von Hoff, D.D. ; Isambert, N. ; Lopez-Martin, J....
European Journal of Cancer.  50 (2014)  - p. 179 , 2014
Link: https://doi.org/10.1016/..
 
?
9

324 Clinical pharmacokinetics (PK), translational PK/pharma..:

Zhou, X. ; Olszanski, A.J. ; Middleton, M....
European Journal of Cancer.  50 (2014)  - p. 105-106 , 2014
Link: https://doi.org/10.1016/..
 
?
10

102 Comparison of platinum/taxane and anthracycline-based t..:

Meade, J. ; Wick, M.J. ; Vaught, T....
European Journal of Cancer.  50 (2014)  - p. 37 , 2014
Link: https://doi.org/10.1016/..
 
?
11

96 Evaluation of hormone therapies in a panel of breast PDX..:

Wick, M.J. ; Vaught, T. ; Gamez, L....
European Journal of Cancer.  50 (2014)  - p. 35 , 2014
Link: https://doi.org/10.1016/..
 
?
12

97 Utilization of low passage adenoid cystic carcinoma PDX ..:

Wick, M.J. ; Meade, J. ; Vaught, T....
European Journal of Cancer.  50 (2014)  - p. 35-36 , 2014
Link: https://doi.org/10.1016/..
 
?
13

620 A Study of PNT2258 (DNA-targeted Blocker of BCL2 Expres..:

Rasco, D.W. ; Patnaik, A. ; Amaya, A....
European Journal of Cancer.  48 (2012)  - p. 191 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Phase 1 study of the pan-RAF inhibitor tovorafenib in patie..:

Rasco, Drew W. ; Medina, Theresa ; Corrie, Pippa...
Cancer Chemotherapy and Pharmacology.  92 (2023)  1 - p. 15-28 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Phase I Study of Glesatinib (MGCD265) in Combination with E..:

Patnaik, Amita ; Gadgeel, Shirish ; Papadopoulos, Kyriakos P....
Targeted Oncology.  17 (2022)  2 - p. 125-138 , 2022
Link: https://doi.org/10.1007/..
 
1-15